Lyme Disease Prophylaxis by Single-Dose Doxycycline in the United States, 2010–2020
Single-dose doxycycline after high-risk tick bites can prevent Lyme disease, which disproportionately affects children. We described single-dose doxycycline dispensings in an outpatient cohort in the United States. During 2010-2020, a total of 427 105 patients received ≥1 dispensing(s); most were aged ≥65 years. Lyme disease postexposure prophylaxis may be underprescribed for some groups, including children.
Authors
- Alison F. Hinckley (ORCID: https://orcid.org/0000-0003-2853-5165)
- Alyssa Beck (ORCID: https://orcid.org/0000-0002-4942-2285)
- Candace C. Fuller (ORCID: https://orcid.org/0000-0002-8902-1435)
- Cate Corey
- Grace E. Marx (ORCID: https://orcid.org/0000-0003-2393-6947)
- Nicole Haug (ORCID: https://orcid.org/0000-0003-4767-5366)
- Jenice S Ko
- Dave Martin
Institutions
- Centers for Disease Control and Prevention (US)
- United States Food and Drug Administration (US)
- Harvard University (US)
- Harvard Pilgrim Health Care (US)
- Cambridge Econometrics (United Kingdom) (GB)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/ofid/ofae593
- Citations
- 1
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.52
Funders
- CVS Health
- Centers for Disease Control and Prevention
- U.S. Food and Drug Administration
- Centers for Medicare and Medicaid Services
- School of Medicine, Duke University